Overview
The Celiac & Gluten Sensitivity (Serum) test examines the presence of IgA and IgG antibodies related to gluten exposure by analysing a venous blood sample. This assessment includes antibodies to tissue transglutaminase, deamidated gliadin peptide, and gliadin, alongside total IgA levels, providing a comprehensive overview of immune activity associated with gluten proteins. By evaluating multiple antibody types, the test offers insight into different immune response profiles linked to gluten intake and supports broader understanding related to dietary and lifestyle factors.
This analysis serves as a tool to help individuals and practitioners explore immune responses to gluten as part of general wellness or nutritional interest. Results can contribute to a broader conversation about digestive health, nutrient absorption, and gut function when considered alongside personal symptom patterns, dietary habits, and family history. Such insights into antibody patterns can help inform lifestyle adjustments, nutritional choices, and ongoing personal health management with the guidance of healthcare or wellness professionals.
Interpretation of results typically involves a holistic view, integrating antibody activity with genetic background and other relevant factors impacting digestive comfort and overall well-being. This approach allows a nuanced understanding of immune interactions with gluten-related proteins, offering valuable information for those interested in optimizing lifestyle and supporting gut balance. The test can thus complement general health monitoring and educational purposes within a wellness framework.
Celiac & Gluten Sensitivity (Serum) is intended for informational, educational, wellness and/or research purposes only. It is not intended for use in medical diagnosis, disease screening or clinical decision-making. Celiac & Gluten Sensitivity (Serum) is not a replacement for clinical laboratory testing and does not provide medical diagnoses. This content is intended for general information within the EU market and should not be interpreted as a regulated in-vitro diagnostic claim.
Practical
Downloads
07-Oct-2025
07-Oct-2025